Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy)

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Bremell, Daniel ^a   Hagberg, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; BACTERIUM ANTIBODY; CORTICOSTEROID; DOXYCYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; BELL PALSY; CELL COUNT; CELL LEVEL; CEREBROSPINAL FLUID; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ERYTHEMA CHRONICUM MIGRANS; FACIAL NERVE PARALYSIS; FEMALE; HUMAN; IDIOPATHIC DISEASE; ISOELECTRIC FOCUSING; LUMBAR PUNCTURE; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; NERVOUS SYSTEM PARAMETERS; NEUROLOGIC DISEASE; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEASONAL VARIATION; TREATMENT PLANNING; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; LEUKOCYTOSIS; MIDDLE AGED; PATHOLOGY; SEASON;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, BACTERIAL; BELL PALSY; CEREBROSPINAL FLUID; CHILD; DIAGNOSIS, DIFFERENTIAL; DOXYCYCLINE; FACIAL PARALYSIS; FEMALE; HUMANS; LEUKOCYTOSIS; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; SEASONS; YOUNG ADULT;

EID: 81155157968     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-215     Document Type: Article

References (24)

1. Morris AM, Deeks SL, Hill MD, Midroni G, Goldstein WC, Mazzulli T, Davidson R, Squires SG, Marrie T, McGeer A, Low DE. Annualized incidence and spectrum of illness from an outbreak investigation of Bell's palsy. Neuroepidemiology 2002, 21:255-261. 10.1159/000065645, 12207155.
2. Finsterer J. Management of peripheral facial nerve palsy. Eur Arch Otorhinolaryngol 2008, 265:743-752. 10.1007/s00405-008-0646-4, 2440925, 18368417.
3. Olsson I, Engervall K, Asbrink E, Carlsson-Nordlander B, Hovmark A. Tick-borne borreliosis and facial palsy. Acta Otolaryngol 1988, 105:100-107.
4. Bjerkhoel A, Carlsson M, Ohlsson J. Peripheral facial palsy caused by the Borrelia spirochete. Acta Otolaryngol 1989, 108:424-430. 10.3109/00016488909125548, 2589070.
5. Halperin JJ, Golightly M. Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology 1992, 42:1268-1270.
6. Peltomaa M, Pyykko I, Seppala I, Viljanen M. Lyme borreliosis and facial paralysis--a prospective analysis of risk factors and outcome. Am J Otolaryngol 2002, 23:125-132. 10.1053/ajot.2002.123434, 12019479.
7. Gilden DH. Clinical practice. Bell's Palsy. N Engl J Med 2004, 351:1323-1331. 10.1056/NEJMcp041120, 15385659.
8. Sullivan FM, Swan IR, Donnan PT, Morrison JM, Smith BH, McKinstry B, Davenport RJ, Vale LD, Clarkson JE, Hammersley V, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med 2007, 357:1598-1607. 10.1056/NEJMoa072006, 17942873.
9. Engstrom M, Berg T, Stjernquist-Desatnik A, Axelsson S, Pitkaranta A, Hultcrantz M, Kanerva M, Hanner P, Jonsson L. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol 2008, 7:993-1000. 10.1016/S1474-4422(08)70221-7, 18849193.
10. Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP, Krupp L, Gronseth G, Bever CT. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2007, 69:91-102. 10.1212/01.wnl.0000265517.66976.28, 17522387.
11. Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 1999, 28:569-574. 10.1086/515145, 10194080.
12. Ljostad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 2008, 7:690-695. 10.1016/S1474-4422(08)70119-4, 18567539.
13. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991, 37:1153-1160.
14. Rath B, Linder T, Cornblath D, Hudson M, Fernandopulle R, Hartmann K, Heininger U, Izurieta H, Killion L, Kokotis P, et al. "All that palsies is not Bell's "--The need to define Bell's palsy as an adverse event following immunization. Vaccine 2007, 26:1-14. 10.1016/j.vaccine.2007.10.043, 18037542.
15. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992, 115(Pt 2):399-423.
16. Hansen K, Lebech AM. Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi--specific immunoglobulin G, A, and M. Ann Neurol 1991, 30:197-205. 10.1002/ana.410300212, 1897911.
17. European Union Concerted Action on Lyme Borreliosis - Case Definitions. , http://meduni09.edis.at/eucalb/cms/index.php?option=com_content&task=view&id=42&Itemid=58
18. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005, 18:484-509. 10.1128/CMR.18.3.484-509.2005, 1195970, 16020686.
19. Dumler JS, Dotevall L, Gustafson R, Granstrom M. A population-based seroepidemiologic study of human granulocytic ehrlichiosis and Lyme borreliosis on the west coast of Sweden. J Infect Dis 1997, 175:720-722. 10.1093/infdis/175.3.720, 9041353.
20. Gustafson R. Epidemiological studies of Lyme borreliosis and tick-borne encephalitis. Scand J Infect Dis Suppl 1994, 92:1-63.
21. Kaiser R. Neuroborreliosis. J Neurol 1998, 245:247-255. 10.1007/s004150050214, 9617704.
22. Engervall K, Carlsson-Nordlander B, Hederstedt B, Berggren D, Bjerkhoel A, Carlborg A, Grenner J, Hanner P, Hogmo A, Isholt RM, et al. Borreliosis as a cause of peripheral facial palsy: a multi-center study. ORL J Otorhinolaryngol Relat Spec 1995, 57:202-206. 10.1159/000276740, 7478454.
23. Lotric-Furlan S, Cimperman J, Maraspin V, Ruzic-Sabljic E, Logar M, Jurca T, Strle F. Lyme borreliosis and peripheral facial palsy. Wien Klin Wochenschr 1999, 111:970-975.
24. Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA. Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999, 18:697-703. 10.1007/s100960050381, 10584895.